Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONET: Darunavir/ritonavir Monotherapy vs Triple Therapy in HIV-1
NCT00458302Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Jun 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00458302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458302.